Shares in Telix Pharmaceutical climbed in morning trade after the company reported positive results from a global phase 3 trial of its advanced prostate cancer treatment, TLX591.

This stock is making its shareholders smile on Tuesday. Let's find out why. The post Why is this ASX 200 share charging 7% higher today? appeared first on The Motley Fool Australia.

The cast of Emmerdale have spoken out following tonight's huge episode in which Cain Dingle revealed the truth to his wife Moira about his cancer diagnosis. Viewers know that Cain was recently ...

Telix Pharmaceuticals reports positive Phase 3 safety results for its investigational prostate cancer therapy, TLX591-Tx. The post Telix Pharmaceuticals reports positive TLX591-Tx Phase 3 results ...

A new study analyzing data from more than 1.8 million people found that vegetarians had significantly lower risks of five types of cancers compared to meat eaters.

The beloved ET alum and "Roundball Rock" maestro, 73, opened up in a new interview with Page Six and shared that he was diagnosed with a rare form of cancer in 2015. Tesh elaborated by saying it's a ...

This article was reviewed by Knox Beasley. Key Takeaways: 1mg oral finasteride effectively treats hair loss and is the ...

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.

In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit desired safety and dosage goals.

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Former ET co-host John Tesh revealed he that he far exceeded the wildest expectations of doctors who diagnosed him with cancer more than a decade ago - but he still lives with the disease.